PharmaShots | Incisive News in 3 Shots

Subscribe Now

DCR-LIV2

Boehringer Ingelheim to Develop Dicerna's GalXC RNAi Candidate for NASH

Boehringer Ingelheim to Develop Dicerna's GalXC RNAi Candidate for NASH

May 25, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us